EVALOSE Drug Patent Profile
✉ Email this page to a colleague
When do Evalose patents expire, and when can generic versions of Evalose launch?
Evalose is a drug marketed by Teva Pharms and is included in one NDA.
The generic ingredient in EVALOSE is lactulose. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Evalose
A generic version of EVALOSE was approved as lactulose by PHARM ASSOC on July 30th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for EVALOSE?
- What are the global sales for EVALOSE?
- What is Average Wholesale Price for EVALOSE?
Summary for EVALOSE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Patent Applications: | 109 |
| DailyMed Link: | EVALOSE at DailyMed |
US Patents and Regulatory Information for EVALOSE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | EVALOSE | lactulose | SOLUTION;ORAL | 073497-001 | May 28, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
